Solta Medical Reports Third Quarter 20...(Provision (benefit) for income taxe...),Health

Date:11/3/2009

Provision (benefit) for income taxes (84) 89 (13) 175 --- --- --- --- Net loss $(6,246) $(1,146) $(10,936) $(1,344) ======= ======= ======== ======= Net loss per share - basic $(0.13) $(0.05) $(0.23) $(0.06) ====== ====== ====== ====== Net loss per share - diluted $(0.13) $(0.05) $(0.23) $(0.06) ====== ====== ====== ====== Weighted average shares outstanding used in calculating net loss per share: Basic 47,855,428 24,067,548 47,807,180 23,861,079 ========== ========== ========== ========== Diluted 47,855,428 24,067,548 47,807,180 23,861,079 ========== ========== ========== ==========

                                Solta Medical, Inc.
     NON-GAAP RECONCILIATION OF GROSS MARGIN, OPERATING INCOME (LOSS), EBITDA,
                 NET INCOME (LOSS) AND NET INCOME (LOSS) PER SHARE
                   (in thousands, except share and per share data)
                                    (unaudited)

                                  Three Months Ended      Nine Months Ended
                                     September 30,          September 30,
                                   2009        2008        2009        2008
                                   ----        ----        ----        ----
    GAAP Gross margin           $10,442      $9,811     $40,820     $35,470
    Non-GAAP adjustments to
     gross margin:
    Purchase price related
     charges                        895           -       4,919           -
    Stock-based compensation         61          53         175         
'/>"/>
SOURCE  Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 
Related medicine news :

1. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
2. Solta Medical to Present at the Maxim Group Growth Conference
3. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
4. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
5. Solta Medical Reports Strong Second Quarter 2009 Results
6. Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
7. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
8. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
11. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting